Humacyte’s Bioengineered Tissue Platform Technology

Medtech Matters

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Juliana Blum, Co-founder and Executive Vice President of Corporate Development at Humacyte. She speaks to the technology behind their regenerative solution and how it can be leveraged as a technology platform to fulfill a variety of bioengineered tissue needs. Specifically, the following questions are addressed.

• What is Humacyte and tell us a bit about your technology?
• What are the applications for bioengineered tissue?
• Obviously without giving away trade secrets, can you tell us a bit about how it is fabricated?
• What were the major challenges that needed to be overcome to develop this?
• What’s ahead for Humacyte?

Listen to this episode and see what you think of the company’s bioengineered tissue technology platform. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at [email protected].

Send us a text

For more medtech news and information, visit https://www.mpomag.com.